<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="bofs" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">bofs</book-part-id>
      <title-group>
        <title>Branchiooculofacial Syndrome</title>
        <alt-title alt-title-type="alt-title">Synonym: BOF Syndrome</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Lin</surname>
            <given-names>Angela E</given-names>
          </name>
          <degrees>MD, FAAP, FACMG</degrees>
          <aff>Genetics Unit<break/>Massachusetts General Hospital for Children<break/>Boston, Massachusetts</aff>
          <email>Lin.angela@mgh.harvard.edu</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Milunsky</surname>
            <given-names>Jeff M</given-names>
          </name>
          <degrees>MD, FACMG</degrees>
          <aff>Boston University School of Medicine<break/>Boston, Massachusetts</aff>
          <email>jmilunsk@bu.edu</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date iso-8601-date="2011-05-31" date-type="created">
          <day>31</day>
          <month>5</month>
          <year>2011</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="bloom" document-type="chapter">Bloom&#x02019;s Syndrome</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="bor" document-type="chapter">Branchiootorenal Spectrum Disorders</related-object>
      <abstract id="bofs.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>The branchiooculofacial syndrome (BOFS) is characterized by: branchial (cervical [90%] or infra- or supra-auricular [60%]) skin defects that range from barely perceptible thin skin or hair patch to erythematous &#x0201c;hemangiomatous&#x0201d; lesions to large weeping erosions; ocular anomalies that can include microphthalmia, anophthalmia, coloboma, and nasolacrimal duct stenosis/atresia; and facial anomalies that can include ocular hypertelorism or telecanthus, broad nasal tip, upslanted palpebral fissures, cleft lip or prominent philtral pillars that give the appearance of a repaired cleft lip (formerly called "pseudocleft lip") with or without cleft palate, upper lip pits and lower facial weakness (asymmetric crying face or partial 7<sup>th</sup> cranial nerve weakness). Malformed and prominent pinnae and hearing loss from inner ear and/or petrous bone anomalies are common. Intellect is usually normal.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The diagnosis is based on clinical findings. <italic toggle="yes">TFAP2A</italic> is the only gene in which pathogenic variants are currently known to cause BOFS.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> In general, children with BOFS should be managed by a multispecialty team including, for example, craniofacial specialists, plastic surgeons, otolaryngologists, and speech therapists. Small, linear or superficial branchial skin defects may heal spontaneously; however, some require surgical intervention. Anophthalmia or severe microphthalmia may require a conformer (a structure, usually plastic, inserted into the eye socket to encourage its growth); nasolacrimal duct stenosis or atresia often requires surgery. It is recommended that cleft lip be repaired by an experienced pediatric plastic surgeon. Lesser forms of cleft lip (&#x0201c;pseudocleft&#x0201d;) may need surgical correction.</p>
          <p><italic toggle="yes">Surveillance:</italic> Monitor for changes related to the major findings over time.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>BOFS is inherited in an autosomal dominant manner. <italic toggle="yes">De novo</italic> pathogenic variants are observed in 50%-60% of affected individuals. Each child of an individual with BOFS has a 50% chance of inheriting the pathogenic variant. Prenatal diagnosis for pregnancies at increased risk is possible if the pathogenic variant has been identified in an affected family member.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="bofs.Diagnosis">
        <title>Diagnosis</title>
        <p><bold>Background.</bold> The branchiooculofacial syndrome (BOFS) is a distinctive craniofacial syndrome first characterized by <xref ref-type="bibr" rid="bofs.REF.lee.1982.345">Lee et al [1982]</xref>, <xref ref-type="bibr" rid="bofs.REF.hall.1983.135">Hall et al [1983]</xref>, and <xref ref-type="bibr" rid="bofs.REF.fujimoto.1987.943">Fujimoto et al [1987]</xref>. <xref ref-type="bibr" rid="bofs.REF.lin.1995.42">Lin et al [1995]</xref> published a large review of the clinical findings. The associated gene (<italic toggle="yes">TFAP2A</italic>) was discovered in 2008 using array comparative genomic hybridization [<xref ref-type="bibr" rid="bofs.REF.milunsky.2008.1171">Milunsky et al 2008</xref>], followed by a large genotype-phenotype analysis [<xref ref-type="bibr" rid="bofs.REF.milunsky.2011.22">Milunsky et al 2011</xref>].</p>
        <sec id="bofs.Clinical_Diagnosis">
          <title>Clinical Diagnosis</title>
          <p>The branchiooculofacial syndrome (BOFS) is diagnosed clinically. There are no formal diagnostic guidelines developed by consensus panels, algorithms using a hierarchy of clinical findings, or evidence-based test standards.</p>
          <p>Diagnostic criteria had been used informally based on the hallmark defects (B, O, F) and were proposed formally in 2011 incorporating the importance of thymic anomalies and independently diagnosed first-degree relatives [<xref ref-type="bibr" rid="bofs.REF.milunsky.2011.22">Milunsky et al 2011</xref>] (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://onlinelibrary.wiley.com/doi/10.1002/ajmg.a.33783/full">full text</ext-link>; see Table I).</p>
          <p>Note: Of the original three features that comprise the mnemonic BOF, the &#x0201c;B&#x0201d; (cutaneous skin defect) is the most distinctive when it is bilateral and anterior cervical in location.</p>
          <p>Diagnostic criteria:</p>
          <list list-type="bullet">
            <list-item>
              <p>All three of the main features are present:</p>
              <list list-type="bullet">
                <list-item>
                  <p>Branchial (cutaneous) skin defect</p>
                </list-item>
                <list-item>
                  <p>Ocular anomaly</p>
                </list-item>
                <list-item>
                  <p>Facial anomalies (characteristic facial appearance) OR</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>Two of the three main features plus one of the following are present:</p>
              <list list-type="bullet">
                <list-item>
                  <p>Affected first-degree relative, independently diagnosed</p>
                </list-item>
                <list-item>
                  <p>Ectopic thymus (dermal)</p>
                </list-item>
              </list>
            </list-item>
          </list>
          <p>Note: In bulleted findings listed below, those in <bold>bold</bold> are present in most affected individuals; findings in <italic toggle="yes">italics</italic> are not present in most affected individuals but are distinctive for BOFS.</p>
          <p>
            <bold>Branchial (cutaneous) defects</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Cervical (90%) or infra- or supra-auricular (60%) <bold>skin defects</bold></p>
            </list-item>
            <list-item>
              <p>Vary from barely perceptible thin skin or hair patch to erythematous &#x0201c;hemangiomatous&#x0201d; lesions to large weeping erosions</p>
            </list-item>
            <list-item>
              <p>Differ from the punctuate sinus tracts of the <related-object link-type="booklink" source-id="gene" document-id="bor" document-type="chapter">branchiootorenal (BOR) syndrome</related-object></p>
            </list-item>
            <list-item>
              <p>Mildest defects may be unrecognized, heal spontaneously</p>
            </list-item>
          </list>
          <p>
            <bold>Ocular anomalies</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Microphthalmia, anophthalmia</p>
            </list-item>
            <list-item>
              <p>Coloboma</p>
            </list-item>
            <list-item>
              <p>Strabismus</p>
            </list-item>
            <list-item>
              <p>Ptosis</p>
            </list-item>
            <list-item>
              <p>Nasolacrimal duct stenosis/atresia</p>
            </list-item>
            <list-item>
              <p>Cataract</p>
            </list-item>
          </list>
          <p>
            <bold>Facial anomalies</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Characteristic appearance</bold> with dolichocephaly, hypertelorism or telecanthus, broad nasal tip, upslanted palpebral fissures (<xref ref-type="fig" rid="bofs.F1">Figure 1</xref>)</p>
            </list-item>
            <list-item>
              <p><bold>Cleft lip</bold> (or <italic toggle="yes">prominent philtral pillars technically known as a lesser form cleft lip</italic> (formerly called <italic toggle="yes">&#x0201c;pseudocleft lip"</italic>), with or without cleft palate (99%), but no isolated cleft palate</p>
            </list-item>
            <list-item>
              <p>Upper lip pits</p>
            </list-item>
            <list-item>
              <p>Lower facial nerve and/or muscle hypoplasia (asymmetric crying face, partial 7<sup>th</sup> cranial nerve weakness)</p>
            </list-item>
            <list-item>
              <p>Inner ear and petrous bone anomalies (As in <related-object link-type="booklink" source-id="gene" document-id="charge" document-type="chapter">CHARGE syndrome</related-object> and the <related-object link-type="booklink" source-id="gene" document-id="bor" document-type="chapter">branchiootorenal syndrome</related-object>, there can be cochlear dysplasia, Mondini dysplasia, and enlarged vestibular aqueduct.)</p>
            </list-item>
            <list-item>
              <p>Malformed and prominent pinnae</p>
            </list-item>
            <list-item>
              <p>Hearing loss (70%) (conductive, sensorineural, mixed)</p>
            </list-item>
          </list>
          <p>
            <bold>Immune system</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>
                <italic toggle="yes">Thymic anomalies (ectopic, dermal)</italic>
              </p>
            </list-item>
          </list>
          <p>
            <bold>Renal system</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Structural anomalies (35%) (dysplastic, absent, multicystic, etc.)</p>
            </list-item>
            <list-item>
              <p>Vesicoureteral reflux</p>
            </list-item>
          </list>
          <p>
            <bold>Ectodermal (hair, teeth, nails)</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p><italic toggle="yes">Premature hair graying (poliosis)</italic> (35%)</p>
            </list-item>
            <list-item>
              <p>Hypoplastic teeth</p>
            </list-item>
            <list-item>
              <p>Dysplastic nails</p>
            </list-item>
            <list-item>
              <p>Cysts (often on the scalp; less commonly in the head and neck region)</p>
            </list-item>
          </list>
          <p>
            <bold>Psychomotor development</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Visual and hearing handicaps (frequent)</p>
            </list-item>
            <list-item>
              <p>Psychomotor performance (usually normal)</p>
            </list-item>
            <list-item>
              <p>Autism spectrum disorder, intellectual disability (rare)</p>
            </list-item>
          </list>
          <p>
            <bold>Growth</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Growth restriction: uncommon</p>
            </list-item>
          </list>
          <p>
            <bold>Rare (&#x0003c;5 patients)</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Heterochromia irides</p>
            </list-item>
            <list-item>
              <p>Congenital heart defect (atrial septal defect, tetralogy of Fallot)</p>
            </list-item>
            <list-item>
              <p>Polydactyly (bilateral, usually post-axial)</p>
            </list-item>
            <list-item>
              <p>Medulloblastoma (described once [<xref ref-type="bibr" rid="bofs.REF.milunsky.2008.1171">Milunsky et al 2008</xref>])</p>
            </list-item>
          </list>
        </sec>
        <sec id="bofs.Molecular_Genetic_Testing">
          <title>Molecular Genetic Testing</title>
          <p><bold>Gene.</bold>
<italic toggle="yes">TFAP2A</italic> is the only gene in which mutation is known to cause branchiooculofacial syndrome.</p>
          <p><bold>Clinical</bold>
<bold>testing</bold></p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Sequence analysis</bold>. More than 95% of individuals who meet the clinical diagnostic criteria for BOFS have <italic toggle="yes">TFAP2A</italic> sequence variants detectable by sequence analysis (i.e., small intragenic deletions/insertions and missense, nonsense, and splice site variants) [<xref ref-type="bibr" rid="bofs.REF.milunsky.2011.22">Milunsky et al 2011</xref>].</p>
            </list-item>
            <list-item>
              <p><bold>Deletion/duplication analysis</bold>. Whole-gene deletions of <italic toggle="yes">TFAP2A</italic> have been described [<xref ref-type="bibr" rid="bofs.REF.milunsky.2008.1171">Milunsky et al 2008</xref>, <xref ref-type="bibr" rid="bofs.REF.gestri.2009.791">Gestri et al 2009</xref>] and likely are present in fewer than 5% of persons with BOFS. Larger deletions of chromosome 6p24-p25 including <italic toggle="yes">TFAP2A</italic> are rare [<xref ref-type="bibr" rid="bofs.REF.davies.1999.708">Davies et al 1999</xref>, <xref ref-type="bibr" rid="bofs.REF.misceo.2008.3230">Misceo et al 2008</xref>]. No partial-gene or exonic deletions or duplications have been reported.</p>
            </list-item>
          </list>
          <table-wrap id="bofs.T.summary_of_molecular_genetic_test" position="anchor" orientation="portrait">
            <label>Table 1. </label>
            <caption>
              <p>Summary of Molecular Genetic Testing Used in Branchiooculofacial Syndrome</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_bofs.T.summary_of_molecular_genetic_test_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_bofs.T.summary_of_molecular_genetic_test_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                  <th id="hd_h_bofs.T.summary_of_molecular_genetic_test_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Variants Detected&#x000a0;<sup>2</sup></th>
                  <th id="hd_h_bofs.T.summary_of_molecular_genetic_test_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Variant Detection Frequency by Test Method&#x000a0;<sup>3</sup></th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_bofs.T.summary_of_molecular_genetic_test_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                    <italic toggle="yes">TFAP2A</italic>
                  </td>
                  <td headers="hd_h_bofs.T.summary_of_molecular_genetic_test_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis<hr/></td>
                  <td headers="hd_h_bofs.T.summary_of_molecular_genetic_test_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sequence variants&#x000a0;<sup>4</sup><hr/></td>
                  <td headers="hd_h_bofs.T.summary_of_molecular_genetic_test_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">&#x0003e;95%<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_bofs.T.summary_of_molecular_genetic_test_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Deletion/duplication analysis&#x000a0;<sup>5</sup></td>
                  <td headers="hd_h_bofs.T.summary_of_molecular_genetic_test_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Whole-gene deletions</td>
                  <td headers="hd_h_bofs.T.summary_of_molecular_genetic_test_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">&#x0003c;5%</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="bofs.TF.1.1">
                <label>1. </label>
                <p>See <related-object source-id="gene" document-id="bofs" object-id="bofs.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
              </fn>
              <fn id="bofs.TF.1.2">
                <label>2. </label>
                <p>See <xref ref-type="sec" rid="bofs.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants.</p>
              </fn>
              <fn id="bofs.TF.1.3">
                <label>3. </label>
                <p>The ability of the test method used to detect a variant that is present in the indicated gene</p>
              </fn>
              <fn id="bofs.TF.1.4">
                <label>4. </label>
                <p>Examples of pathogenic variants detected by sequence analysis may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
              <fn id="bofs.TF.1.5">
                <label>5. </label>
                <p>Testing that identifies deletions/duplications not readily detectable by sequence analysis of the coding and flanking intronic regions of genomic DNA; included in the variety of methods that may be used are: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and chromosomal microarray (CMA) that includes this gene/chromosome segment.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
        <sec id="bofs.Testing_Strategy">
          <title>Testing Strategy</title>
          <p>
            <bold>To confirm/establish the diagnosis in a proband</bold>
          </p>
          <list list-type="order">
            <list-item>
              <label>1</label>
              <p>Clinical examination for the diagnostic features</p>
            </list-item>
            <list-item>
              <label>2</label>
              <p>For those meeting clinical diagnostic criteria, sequence analysis of the seven coding exons and intron/exon boundaries of <italic toggle="yes">TFAP2A</italic></p>
            </list-item>
            <list-item>
              <label>3</label>
              <p>If a pathogenic variant is not detected on sequence analysis, deletion/duplication analysis</p>
            </list-item>
          </list>
          <p><bold>Prenatal diagnosis and preimplantation genetic diagnosis (PGD)</bold> for at-risk pregnancies require prior identification of the pathogenic variant in the family.</p>
        </sec>
      </sec>
      <sec id="bofs.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="bofs.Clinical_Description">
          <title>Clinical Description</title>
          <p>Females and males are affected equally.</p>
          <p><bold>Newborns</bold> with clefts have the expected challenges to feeding, and possibly breathing.</p>
          <p><bold>Infants</bold> with clefts need support to feed properly, and do best when in the care of an established cleft palate team. Some of the smaller skin defects start to &#x0201c;heal&#x0201d; by secondary intention. Nasolacrimal duct stenosis or atresia lead to weeping eyes, and require the attention of a pediatric ophthalmologist.</p>
          <p><bold>In childhood</bold>, individuals with BOFS are coping with cosmetic, visual, hearing, and speech challenges. They may have strabismus; some have significant visual impairment. The most severely affected children have surgical, medical, cosmetic and learning needs similar to many other children with craniofacial disorders. However, mildly affected children may appear to need little support.</p>
          <p><bold>Adolescents</bold> may have issues with anxiety and social esteem. These appear to be more than the experience of living with a cleft lip and other craniofacial anomalies, but the number of affected individuals is small.</p>
          <p>Most have normal intellect.</p>
          <p><bold>Adults</bold> with typical BOFS have usually been diagnosed in childhood. Individuals with very mild features may not be diagnosed until they give birth to a classically affected child. The observation that adults can be asymptomatic or minimally affected illustrates the variable expression of pathogenic variants in this gene.</p>
          <p>Fertility does not appear to be affected.</p>
        </sec>
        <sec id="bofs.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>Genotype/phenotype correlations for pathogenic variants within <italic toggle="yes">TFAP2A</italic> are not well established.</p>
          <p>A genotype-phenotype analysis of 41 individuals in 30 families was based on diagnostic criteria that were fulfilled in 87% [<xref ref-type="bibr" rid="bofs.REF.milunsky.2011.22">Milunsky et al 2011</xref>]. Significant inter- and intrafamilial variability were observed with the same pathogenic variants [<xref ref-type="bibr" rid="bofs.REF.milunsky.2011.22">Milunsky et al 2011</xref>]. Missense, frameshift, and splicing variants along with more complex rearrangements [<xref ref-type="bibr" rid="bofs.REF.tekin.2009.427">Tekin et al 2009</xref>, <xref ref-type="bibr" rid="bofs.REF.milunsky.2011.22">Milunsky et al 2011</xref>] throughout the gene result in similar phenotypes.</p>
          <p>The absence of overt clefting is noted in the few individuals who have whole-gene deletions [<xref ref-type="bibr" rid="bofs.REF.milunsky.2008.1171">Milunsky et al 2008</xref>, <xref ref-type="bibr" rid="bofs.REF.gestri.2009.791">Gestri et al 2009</xref>] and larger chromosomal deletions that include <italic toggle="yes">TFAP2A</italic> [<xref ref-type="bibr" rid="bofs.REF.davies.1999.708">Davies et al 1999</xref>, <xref ref-type="bibr" rid="bofs.REF.misceo.2008.3230">Misceo et al 2008</xref>]. All individuals with a deletion appear to have an abnormally prominent philtrum that may be on the spectrum of microform cleft lip [<xref ref-type="bibr" rid="bofs.REF.lin.2009.608">Lin et al 2009</xref>]. Otherwise the marked inter- and intrafamilial variability appear similar to that observed with intragenic pathogenic variants.</p>
          <p>To date information is insufficient to make generalizations about the presence of autistic features and severe intellectual disability in BOFS since only two instances have been noted.</p>
          <list list-type="bullet">
            <list-item>
              <p>Patient SP2 reported by <xref ref-type="bibr" rid="bofs.REF.reiber.2010.994">Reiber et al [2010]</xref>, who had the pathogenic variant c.806T&#x0003e;C, had both severe intellectual disability and autism.</p>
            </list-item>
            <list-item>
              <p>Patient 3 reported by <xref ref-type="bibr" rid="bofs.REF.gestri.2009.791">Gestri et al [2009]</xref>, who had a whole-gene deletion, had autistic features.</p>
            </list-item>
          </list>
        </sec>
        <sec id="bofs.Penetrance">
          <title>Penetrance</title>
          <p>BOFS has shown almost complete penetrance. Careful examination of individuals identified in a family with BOFS with a <italic toggle="yes">TFAP2A</italic> pathogenic variant is necessary to reveal subtle findings including premature graying (individuals may have dyed their hair), faint hair on the neck, or heterochromia of the irides.</p>
        </sec>
        <sec id="bofs.Anticipation">
          <title>Anticipation</title>
          <p>Not enough data have been reported to assess whether anticipation may occur in BOFS. This is especially difficult because of the marked clinical variability in this disorder. Five of six families with BOFS with no mosaicism identified had apparently more &#x0201c;severe&#x0201d; findings in subsequent generations [<xref ref-type="bibr" rid="bofs.REF.milunsky.2011.22">Milunsky et al 2011</xref>]. Further study is necessary.</p>
        </sec>
        <sec id="bofs.Nomenclature">
          <title>Nomenclature</title>
          <p>The term &#x0201c;branchiooculofacial syndrome&#x0201d; was suggested by <xref ref-type="bibr" rid="bofs.REF.fujimoto.1987.943">Fujimoto et al [1987]</xref>. No other name has been used for this distinctive syndrome.</p>
        </sec>
        <sec id="bofs.Prevalence">
          <title>Prevalence</title>
          <p>BOFS is rare, with fewer than 100 well-described cases with molecular genetic analysis. The prevalence is not known.</p>
        </sec>
      </sec>
      <sec id="bofs.Genetically_Related_Allelic_Disorde">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>No other phenotypes are known to be associated with mutation of <italic toggle="yes">TFAP2A.</italic></p>
      </sec>
      <sec id="bofs.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Phenotypic overlap with the <related-object link-type="booklink" source-id="gene" document-id="bor" document-type="chapter">branchiootorenal (BOR) syndrome</related-object> has been suggested, but BOFS has more distinctive craniofacial anomalies, and the two should not be confused.</p>
        <p>Although there may appear to be superficial overlap in some of the findings, there should be no confusion in differentiating BOFS from <related-object link-type="booklink" source-id="gene" document-id="charge" document-type="chapter">CHARGE syndrome</related-object> since the latter does not have skin defects, and BOFS does not have choanal atresia. The abnormal pinna and inner ear anomalies differ.</p>
      </sec>
      <sec id="bofs.Management">
        <title>Management</title>
        <sec id="bofs.Evaluations_Following_Initial_Diagn">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs of an individual diagnosed with the branchiooculofacial syndrome (BOFS), the following studies are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>CT imaging of the temporal bone to anticipate optimal hearing correction [<xref ref-type="bibr" rid="bofs.REF.raveh.2000.149">Raveh et al 2000</xref>, <xref ref-type="bibr" rid="bofs.REF.tekin.2009.427">Tekin et al 2009</xref>, <xref ref-type="bibr" rid="bofs.REF.stoetzel.2009.2141">Stoetzel et al 2009</xref>]</p>
            </list-item>
            <list-item>
              <p>Echocardiogram if there is a murmur or cardiac symptoms</p>
            </list-item>
            <list-item>
              <p>Renal ultrasonography</p>
            </list-item>
          </list>
          <p>The following consultations are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Examination of the skin defects by a pediatric plastic surgeon to delineate the extent of the lesion(s), to determine if there is a sinus and, most importantly, to determine if a thymic remnant could be present</p>
            </list-item>
            <list-item>
              <p>Formal evaluation of cleft lip/palate and other possible facial abnormalities by a cleft lip/palate team, which often includes a clinical geneticist, pediatric plastic surgeon, otorhinolaryngologist, speech and language therapist, dental and orthodontic specialist, and ophthalmologist</p>
            </list-item>
            <list-item>
              <p>Complete eye examination by a pediatric ophthalmologist to assess for visual limitations, strabismus, and nasolacrimal duct obstruction</p>
            </list-item>
            <list-item>
              <p>Referral of those with anophthalmia and/or severe microphthalmia to support services for the visually impaired</p>
            </list-item>
            <list-item>
              <p>Referral to a nephrologist if renal abnormalities are identified</p>
            </list-item>
            <list-item>
              <p>Referral to an audiologist</p>
            </list-item>
            <list-item>
              <p>For those with a cleft, assessment by a speech therapist</p>
            </list-item>
            <list-item>
              <p>Development assessment particularly for children with visual and/or hearing problems</p>
            </list-item>
            <list-item>
              <p>Monitoring for depression, attention dysregulation</p>
            </list-item>
          </list>
          <p>Note: Motor delays are not part of BOFS, and thus, physical and occupational therapy is not anticipated.</p>
        </sec>
        <sec id="bofs.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p><xref ref-type="bibr" rid="bofs.REF.milunsky.2011.22">Milunsky et al [2011]</xref> provided <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://onlinelibrary.wiley.com/doi/10.1002/ajmg.a.33783/full">management guidelines</ext-link>.</p>
          <p>In general, children with BOFS and multiple anomalies should be followed in a setting in which multispecialty care can be provided by a team including, for example, craniofacial specialists, plastic surgeons, otolaryngologists, and speech therapists [adapted from <xref ref-type="bibr" rid="bofs.REF.milunsky.2011.22">Milunsky et al 2011</xref>] (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://onlinelibrary.wiley.com/doi/10.1002/ajmg.a.33783/full">full text</ext-link>; see Table III).</p>
          <p>Ideally, multispecialty evaluations and surgery should be performed within a craniofacial clinic. Surgical treatment should be done only by a pediatric plastic surgeon experienced in treating cleft lip. Lesser forms of cleft lip (formerly known as &#x0201c;pseudocleft&#x0201d;) may need surgical correction [<xref ref-type="bibr" rid="bofs.REF.lin.2009.608">Lin et al 2009</xref>]. In addition to the nasal tip flattening or asymmetry that may be associated with cleft lip, a characteristic full, flat nasal tip may need a corrective procedure. In addition affected individuals may need reconstruction of malformed protruding pinnae. If diagnosed in early infancy, auricular molding may be indicated.</p>
          <p>When branchial or supra-auricular skin defects are small, linear, or superficial, they may heal spontaneously. The larger skin defects should be treated like a moist &#x0201c;wound&#x0201d; by a plastic surgeon, but generally do not need surgical intervention. They should not be cauterized. Most larger skin defects require surgical excision. Importantly, a sinus tract must be dissected by an experienced pediatric plastic surgeon. Exploration for a thymic remnant may be necessary, which should be sent for histopathologic examination.</p>
          <p>Obstruction from nasolacrimal duct stenosis or atresia must be relieved and monitored for restenosis. Severe microphthalmia or anophthalmia may be managed by inserting a conformer into the eye socket to encourage its growth.</p>
          <p>Hearing loss is treated routinely (see <related-object link-type="booklink" source-id="gene" document-id="deafness-overview" document-type="chapter">Deafness and Hereditary Hearing Loss Overview</related-object>).</p>
          <p>The teeth should be monitored for size and number, caries, and malocclusion.</p>
          <p>Sensory, psychologic, and developmental challenges should be treated with supportive therapies. Currently, data are insufficient to make recommendations that more severely affected individuals require more psychologic support.</p>
        </sec>
        <sec id="bofs.Surveillance">
          <title>Surveillance</title>
          <p>Monitor for changes related to the major findings over time.</p>
          <p>Monitor older children as they enter adolescence for signs of low self-esteem and other psychologic issues.</p>
        </sec>
        <sec id="bofs.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>See <xref ref-type="sec" rid="bofs.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="bofs.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ClinicalTrials.gov">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p>
        </sec>
      </sec>
      <sec id="bofs.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="bofs.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>Branchiooculofacial syndrome (BOFS) is inherited in an autosomal dominant manner.</p>
        </sec>
        <sec id="bofs.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>A significant proportion (~40%-50%) of individuals diagnosed with BOFS have an affected parent [<xref ref-type="bibr" rid="bofs.REF.milunsky.2011.22">Milunsky et al 2011</xref>].</p>
            </list-item>
            <list-item>
              <p>A proband with BOFS may have the disorder as the result of a <italic toggle="yes">de novo</italic> pathogenic variant. The proportion of cases caused by <italic toggle="yes">de novo</italic> mutation approximates 50%-60% [<xref ref-type="bibr" rid="bofs.REF.milunsky.2011.22">Milunsky et al 2011</xref>].</p>
            </list-item>
            <list-item>
              <p>It is recommended that parents of a proband have molecular genetic testing for the family-specific pathogenic variant to facilitate accurate recurrence risk counseling. Evaluation of parents may determine that one is affected but has escaped previous diagnosis because of failure by health care professionals to recognize the syndrome and/or a milder phenotypic presentation. Therefore, an apparently negative family history cannot be confirmed until molecular testing has been completed.</p>
            </list-item>
          </list>
          <p>Note: (1) Although about 40%-50% of individuals diagnosed with BOFS have an affected parent, the family history may appear to be negative because of failure to recognize the disorder in family members or early death of the parent before the manifestation of symptoms (e.g., premature graying). (2) If the parent is the individual in whom the pathogenic variant first occurred s/he may have somatic mosaicism for the variant and may be mildly/minimally affected.</p>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to the sibs of the proband depends on the genetic status of the proband&#x02019;s parents: if a parent of the proband is affected and/or has a <italic toggle="yes">TFAP2A</italic> pathogenic variant, the risk to the sibs of inheriting the pathogenic variant is 50%.</p>
            </list-item>
            <list-item>
              <p>When the parents are clinically unaffected (after careful examination), the risk to the sibs of a proband appears to be low.</p>
            </list-item>
            <list-item>
              <p>The sibs of a proband with clinically unaffected parents are still at increased risk for BOFS because of the possibility of variable expressivity and/or germline mosaicism in a parent.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> Each child of an individual with BOFS has a 50% chance of inheriting the pathogenic variant.</p>
          <p><bold>Other family members of a proband.</bold> The risk to other family members depends on the status of the proband's parents: if a parent is affected, his or her family members may be at risk.</p>
        </sec>
        <sec id="bofs.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p>To determine if a parent, child, or other family member could be affected, a careful physical examination is the most important &#x0201c;test.&#x0201d;</p>
          <p><bold>Considerations in families with an apparent <italic toggle="yes">de novo</italic> pathogenic variant.</bold> When neither parent of a proband with an autosomal dominant condition has clinical evidence of the disorder, it is likely that the proband has a <italic toggle="yes">de novo</italic> pathogenic variant. However, the variable expressivity of BOFS warrants molecular testing of parents for more accurate recurrence risk counseling. Possible non-medical explanations including alternate paternity or maternity (e.g., with assisted reproduction) or undisclosed adoption could also be explored.</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling&#x000a0;(including discussion of potential risks to offspring and reproductive options) to young adults who are affected.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="bofs.Prenatal_Testing_and_Preimplantatio">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p><bold>Molecular genetic testing.</bold> Once the <italic toggle="yes">TFAP2A</italic> pathogenic variant has been identified in an affected family member, prenatal diagnosis and preimplantation genetic diagnosis for a pregnanciy at increased risk for BOFS are possible options.</p>
          <p><bold>Ultrasound examination.</bold> A systematic review of the prenatal features of BOFS has not been conducted. It is possible that prenatal detection of cleft lip/palate in a fetus at increased risk for BOFS would allow the syndrome to be diagnosed.</p>
        </sec>
      </sec>
      <sec id="bofs.Resources">
        <title>Resources</title>
      </sec>
      <sec id="bofs.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <sec id="bofs.Molecular_Genetic_Pathogenesis">
          <title>Molecular Genetic Pathogenesis</title>
          <p>TFAP2A is a retinoic acid-responsive member of the AP-2 family of transcription factors that regulate gene expression during embryogenesis of the eye, ear, face, body wall, limbs, and neural tube [<xref ref-type="bibr" rid="bofs.REF.schorle.1996.235">Schorle et al 1996</xref>, <xref ref-type="bibr" rid="bofs.REF.zhang.1996.238">Zhang et al 1996</xref>, <xref ref-type="bibr" rid="bofs.REF.ahituv.2004.424">Ahituv et al 2004</xref>, <xref ref-type="bibr" rid="bofs.REF.nelson.2004.72">Nelson &#x00026; Williams 2004</xref>].</p>
          <p><bold>Gene structure.</bold>
<italic toggle="yes">TFAP2A</italic> contains seven coding exons (reference sequence <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_003220.2">NM_003220.2</ext-link>). For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="bofs" object-id="bofs.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
          <p><bold>Pathogenic allelic variants.</bold> Pathogenic variants within <italic toggle="yes">TFAP2A</italic> or deletion of the entire gene result in the branchiooculofacial (BOF) syndrome. <xref ref-type="bibr" rid="bofs.REF.milunsky.2008.1171">Milunsky et al [2008]</xref> described a familial whole-gene deletion and four <italic toggle="yes">de novo</italic> missense variants in simplex cases (i.e., a single occurrence in the family) that resulted in BOFS. Additional pathogenic variants and another familial deletion have now been described [<xref ref-type="bibr" rid="bofs.REF.gestri.2009.791">Gestri et al 2009</xref>, <xref ref-type="bibr" rid="bofs.REF.stoetzel.2009.2141">Stoetzel et al 2009</xref>, <xref ref-type="bibr" rid="bofs.REF.tekin.2009.427">Tekin et al 2009</xref>, <xref ref-type="bibr" rid="bofs.REF.reiber.2010.994">Reiber et al 2010</xref>].</p>
          <p>Although the pathogenic variants occur throughout the gene, a hotspot region in exons 4 and 5 that harbors missense variants in about 90% of probands/families with BOFS has been identified [<xref ref-type="bibr" rid="bofs.REF.milunsky.2011.22">Milunsky et al 2011</xref>]. Recurrent pathogenic variants are now well recognized (<xref ref-type="table" rid="bofs.T.recurrent_tfap2a_pathogenic_varia">Table 2</xref>).</p>
          <p>Mosaicism has been detected in one family [<xref ref-type="bibr" rid="bofs.REF.milunsky.2011.22">Milunsky et al 2011</xref>].</p>
          <p>The molecular spectrum in 30 families with 41 affected individuals with BOFS included heterozygous missense variants (28/30; 93%), one frameshift variant, and one whole-gene deletion [<xref ref-type="bibr" rid="bofs.REF.milunsky.2011.22">Milunsky et al 2011</xref>]. <xref ref-type="bibr" rid="bofs.REF.tekin.2009.427">Tekin et al [2009]</xref> reported a complex <italic toggle="yes">TFAP2A</italic> allele (deletion of 18 and insertion of 6 nucleotides) between amino acids 276 and 281 in an individual with BOFS.</p>
          <table-wrap id="bofs.T.recurrent_tfap2a_pathogenic_varia" position="anchor" orientation="portrait">
            <label>Table 2. </label>
            <caption>
              <p>Recurrent <italic toggle="yes">TFAP2A</italic> Pathogenic Variants Revealing a Mutational Hotspot</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_bofs.T.recurrent_tfap2a_pathogenic_varia_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Exon</th>
                  <th id="hd_h_bofs.T.recurrent_tfap2a_pathogenic_varia_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                  <th id="hd_h_bofs.T.recurrent_tfap2a_pathogenic_varia_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Protein Amino Acid Change</th>
                  <th id="hd_h_bofs.T.recurrent_tfap2a_pathogenic_varia_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_bofs.T.recurrent_tfap2a_pathogenic_varia_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">4<hr/></td>
                  <td headers="hd_h_bofs.T.recurrent_tfap2a_pathogenic_varia_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">c.709C&#x0003e;G<hr/></td>
                  <td headers="hd_h_bofs.T.recurrent_tfap2a_pathogenic_varia_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Arg237Gly<hr/></td>
                  <td headers="hd_h_bofs.T.recurrent_tfap2a_pathogenic_varia_1_1_1_4" rowspan="9" valign="middle" align="left" colspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_003220.2">NM_003220.2</ext-link>
<break/><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_003211.1">NP_003211.1</ext-link></td>
                </tr>
                <tr>
                  <td headers="hd_h_bofs.T.recurrent_tfap2a_pathogenic_varia_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">4<hr/></td>
                  <td headers="hd_h_bofs.T.recurrent_tfap2a_pathogenic_varia_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">c.710G&#x0003e;C<hr/></td>
                  <td headers="hd_h_bofs.T.recurrent_tfap2a_pathogenic_varia_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Arg237Pro<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_bofs.T.recurrent_tfap2a_pathogenic_varia_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">4<hr/></td>
                  <td headers="hd_h_bofs.T.recurrent_tfap2a_pathogenic_varia_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">c.724G&#x0003e;A<hr/></td>
                  <td headers="hd_h_bofs.T.recurrent_tfap2a_pathogenic_varia_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Glu242Lys<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_bofs.T.recurrent_tfap2a_pathogenic_varia_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">4<hr/></td>
                  <td headers="hd_h_bofs.T.recurrent_tfap2a_pathogenic_varia_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">c.752G&#x0003e;A<hr/></td>
                  <td headers="hd_h_bofs.T.recurrent_tfap2a_pathogenic_varia_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Gly251Glu<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_bofs.T.recurrent_tfap2a_pathogenic_varia_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">4<hr/></td>
                  <td headers="hd_h_bofs.T.recurrent_tfap2a_pathogenic_varia_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">c.760A&#x0003e;G<hr/></td>
                  <td headers="hd_h_bofs.T.recurrent_tfap2a_pathogenic_varia_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Arg254Gly<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_bofs.T.recurrent_tfap2a_pathogenic_varia_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">4<hr/></td>
                  <td headers="hd_h_bofs.T.recurrent_tfap2a_pathogenic_varia_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">c.760A&#x0003e;T<hr/></td>
                  <td headers="hd_h_bofs.T.recurrent_tfap2a_pathogenic_varia_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Arg254Trp<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_bofs.T.recurrent_tfap2a_pathogenic_varia_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">4<hr/></td>
                  <td headers="hd_h_bofs.T.recurrent_tfap2a_pathogenic_varia_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">c.761G&#x0003e;C<hr/></td>
                  <td headers="hd_h_bofs.T.recurrent_tfap2a_pathogenic_varia_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Arg254Pro<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_bofs.T.recurrent_tfap2a_pathogenic_varia_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">4<hr/></td>
                  <td headers="hd_h_bofs.T.recurrent_tfap2a_pathogenic_varia_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">c.763A&#x0003e;G<hr/></td>
                  <td headers="hd_h_bofs.T.recurrent_tfap2a_pathogenic_varia_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Arg255Gly<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_bofs.T.recurrent_tfap2a_pathogenic_varia_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">5</td>
                  <td headers="hd_h_bofs.T.recurrent_tfap2a_pathogenic_varia_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">c.767C&#x0003e;T</td>
                  <td headers="hd_h_bofs.T.recurrent_tfap2a_pathogenic_varia_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">p.Ala256Val</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn>
                <p>Table adapted from Table III in <xref ref-type="bibr" rid="bofs.REF.milunsky.2011.22">Milunsky et al [2011]</xref>.</p>
              </fn>
              <fn>
                <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
              </fn>
              <fn>
                <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p><bold>Normal gene product.</bold> TFAP2A protein comprises 437 amino acids. It has a central basic DNA binding region, a carboxy terminus helix-span-helix motif that mediates dimerization, and an amino terminus that contains a transactivation domain [<xref ref-type="bibr" rid="bofs.REF.eckert.2005.246">Eckert et al 2005</xref>]. The amino acids in the basic region of the DNA binding domain (exons 4 and 5) show high evolutionary conservation from <italic toggle="yes">Homo sapiens</italic> through <italic toggle="yes">Ciona intestinalis</italic> (transparent sea squirt) [<xref ref-type="bibr" rid="bofs.REF.milunsky.2008.1171">Milunsky et al 2008</xref>].</p>
          <p>In addition to its role in regulating gene expression during embryogenesis, <italic toggle="yes">TFAP2A</italic> is also involved in tumorigenesis with protein expression levels affecting cell transformation, tumor growth, metastasis, and survival [<xref ref-type="bibr" rid="bofs.REF.jean.1998.16501">Jean et al 1998</xref>, <xref ref-type="bibr" rid="bofs.REF.heimberger.2005.267">Heimberger et al 2005</xref>, <xref ref-type="bibr" rid="bofs.REF.orso.2007.87">Orso et al 2007</xref>]. Numerous gene interactions likely underlie the variability in phenotype resulting from molecular defects involving TFAP2A. TFAP2A is known to be expressed in premigratory and migratory neural crest cells [<xref ref-type="bibr" rid="bofs.REF.hilgereversheim.2000.1">Hilger-Eversheim et al 2000</xref>, <xref ref-type="bibr" rid="bofs.REF.li.2007.338">Li &#x00026; Cornell, 2007</xref>] and is required for early morphogenesis of the lens [<xref ref-type="bibr" rid="bofs.REF.gestri.2009.791">Gestri et al 2009</xref>].</p>
          <p><bold>Abnormal gene product.</bold> In humans, the described anomalies in BOFS appear to be related to pathogenic variants or deletions of <italic toggle="yes">TFAP2A</italic> leading to dysfunctional regulation especially during embryogenesis.</p>
          <p>Loss or alteration of function of TFAP2A protein orthologs in zebrafish or mice result in facial clefting, limb anomalies, and defects of the eye, ear, body wall, neural tube, and heart outflow tract [<xref ref-type="bibr" rid="bofs.REF.schorle.1996.235">Schorle et al 1996</xref>, <xref ref-type="bibr" rid="bofs.REF.zhang.1996.238">Zhang et al 1996</xref>, <xref ref-type="bibr" rid="bofs.REF.nottoli.1998.13714">Nottoli et al 1998</xref>, <xref ref-type="bibr" rid="bofs.REF.westmays.1999.46">West-Mays et al 1999</xref>, <xref ref-type="bibr" rid="bofs.REF.brewer.2002.139">Brewer et al 2002</xref>, <xref ref-type="bibr" rid="bofs.REF.holzschuh.2003.5741">Holzschuh et al 2003</xref>, <xref ref-type="bibr" rid="bofs.REF.knight.2003.5755">Knight et al 2003</xref>, <xref ref-type="bibr" rid="bofs.REF.ahituv.2004.424">Ahituv et al 2004</xref>, <xref ref-type="bibr" rid="bofs.REF.brewer.2004.135">Brewer et al 2004</xref>, <xref ref-type="bibr" rid="bofs.REF.nelson.2004.72">Nelson &#x00026; Williams 2004</xref>, <xref ref-type="bibr" rid="bofs.REF.feng.2008.315">Feng et al 2008</xref>]. <xref ref-type="bibr" rid="bofs.REF.gestri.2009.791">Gestri et al [2009]</xref> studied the role of <italic toggle="yes">TFAP2A</italic> pathogenic variants in zebrafish eye morphogenesis that revealed an association with a multitude of ocular pathologies. In addition, the pathogenic variants compromised the gene function, thereby sensitizing the developing eye to deleterious mutation of other genes including <italic toggle="yes">bmp4</italic> and <italic toggle="yes">tcf711a</italic> [<xref ref-type="bibr" rid="bofs.REF.gestri.2009.791">Gestri et al 2009</xref>]. <xref ref-type="bibr" rid="bofs.REF.damberg.2005.1281">Damberg [2005]</xref> found that the AP-2 family may be involved in the regulation of the monoaminergic systems in the adult brain, resulting in neuropsychiatric disorders. <xref ref-type="bibr" rid="bofs.REF.brewer.2004.135">Brewer et al [2004]</xref> noted that surviving mutated <italic toggle="yes">Tcfap2a</italic> mice have craniofacial anomalies, abnormal middle ear development, and defects in pigmentation.</p>
        </sec>
      </sec>
      <sec id="bofs.References">
        <title>References</title>
        <sec id="bofs.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="bofs.Literature_Cited.reflist0">
            <ref id="bofs.REF.ahituv.2004.424">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ahituv</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Erven</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fuchs</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guy</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ashery-Padan</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Williams</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Angelis</surname>
                    <given-names>MH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Avraham</surname>
                    <given-names>KB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steel</surname>
                    <given-names>KP</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>An ENU-induced mutation in AP-2alpha leads to middle ear and ocular defects in Doarad mice.</article-title>
                <source>Mamm Genome.</source>
                <volume>15</volume>
                <fpage>424</fpage>
                <lpage>32</lpage>
                <pub-id pub-id-type="pmid">15181535</pub-id>
              </element-citation>
            </ref>
            <ref id="bofs.REF.brewer.2002.139">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Brewer</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jiang</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Donaldson</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Williams</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sucov</surname>
                    <given-names>HM</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Requirement for AP-2alpha in cardiac outflow tract morphogenesis.</article-title>
                <source>Mech Dev.</source>
                <volume>110</volume>
                <fpage>139</fpage>
                <lpage>49</lpage>
                <pub-id pub-id-type="pmid">11744375</pub-id>
              </element-citation>
            </ref>
            <ref id="bofs.REF.brewer.2004.135">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Brewer</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Feng</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huang</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sullivan</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Williams</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Wnt1-Cre-mediated deletion of AP-2alpha causes multiple neural crest-related defects.</article-title>
                <source>Dev Biol.</source>
                <volume>267</volume>
                <fpage>135</fpage>
                <lpage>52</lpage>
                <pub-id pub-id-type="pmid">14975722</pub-id>
              </element-citation>
            </ref>
            <ref id="bofs.REF.damberg.2005.1281">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Damberg</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Transcription factor AP-2 and monoaminergic functions in the central nervous system.</article-title>
                <source>J Neural Transm.</source>
                <volume>112</volume>
                <fpage>1281</fpage>
                <lpage>96</lpage>
                <pub-id pub-id-type="pmid">15959839</pub-id>
              </element-citation>
            </ref>
            <ref id="bofs.REF.davies.1999.708">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Davies</surname>
                    <given-names>AF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mirza</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Flinter</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ragoussis</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>An interstitial deletion of 6p24-p25 proximal to the FKHL7 locus and including AP-2alpha that affects anterior eye chamber development.</article-title>
                <source>J Med Genet.</source>
                <volume>36</volume>
                <fpage>708</fpage>
                <lpage>10</lpage>
                <pub-id pub-id-type="pmid">10507730</pub-id>
              </element-citation>
            </ref>
            <ref id="bofs.REF.eckert.2005.246">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Eckert</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buhl</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weber</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>J&#x000e4;ger</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schorle</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>The AP-2 family of transcription factors.</article-title>
                <source>Genome Biol.</source>
                <volume>6</volume>
                <fpage>246</fpage>
                <pub-id pub-id-type="pmid">16420676</pub-id>
              </element-citation>
            </ref>
            <ref id="bofs.REF.feng.2008.315">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Feng</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huang</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Williams</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Identification and analysis of a conserved Tcfap2a intronic enhancer element required for expression in facial and limb bud mesenchyme.</article-title>
                <source>Mol Cell Biol.</source>
                <volume>28</volume>
                <fpage>315</fpage>
                <lpage>25</lpage>
                <pub-id pub-id-type="pmid">17984226</pub-id>
              </element-citation>
            </ref>
            <ref id="bofs.REF.fujimoto.1987.943">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fujimoto</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lipson</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lacro</surname>
                    <given-names>RV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shinno</surname>
                    <given-names>NW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boelter</surname>
                    <given-names>WD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jones</surname>
                    <given-names>KL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilson</surname>
                    <given-names>MG</given-names>
                  </name>
                </person-group>
                <year>1987</year>
                <article-title>New autosomal dominant branchio-oculo-facial syndrome.</article-title>
                <source>Am J Med Genet.</source>
                <volume>27</volume>
                <fpage>943</fpage>
                <lpage>51</lpage>
                <pub-id pub-id-type="pmid">3321995</pub-id>
              </element-citation>
            </ref>
            <ref id="bofs.REF.gestri.2009.791">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gestri</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Osborne</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wyatt</surname>
                    <given-names>AW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gerrelli</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gribble</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stewart</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fryer</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bunyan</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prescott</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Collin</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fitzgerald</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robinson</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carter</surname>
                    <given-names>NP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilson</surname>
                    <given-names>SW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ragge</surname>
                    <given-names>NK</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Reduced TFAP2A function causes variable optic fissure closure and retinal defects and sensitizes eye development to mutations in other morphogenetic regulators.</article-title>
                <source>Hum Genet.</source>
                <volume>126</volume>
                <fpage>791</fpage>
                <lpage>803</lpage>
                <pub-id pub-id-type="pmid">19685247</pub-id>
              </element-citation>
            </ref>
            <ref id="bofs.REF.hall.1983.135">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hall</surname>
                    <given-names>BD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>deLorimier</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Foster</surname>
                    <given-names>LH</given-names>
                  </name>
                </person-group>
                <year>1983</year>
                <article-title>Brief clinical report: a new syndrome of hemangiomatous branchial clefts, lip pseudoclefts, and unusual facial appearance.</article-title>
                <source>Am J Med Genet.</source>
                <volume>14</volume>
                <fpage>135</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">6829601</pub-id>
              </element-citation>
            </ref>
            <ref id="bofs.REF.heimberger.2005.267">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Heimberger</surname>
                    <given-names>AB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGary</surname>
                    <given-names>EC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suki</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ruiz</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fuller</surname>
                    <given-names>GN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bar-Eli</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Loss of the AP-2alpha transcription factor is associated with the grade of human gliomas.</article-title>
                <source>Clin Cancer Res.</source>
                <volume>11</volume>
                <fpage>267</fpage>
                <lpage>72</lpage>
                <pub-id pub-id-type="pmid">15671555</pub-id>
              </element-citation>
            </ref>
            <ref id="bofs.REF.hilgereversheim.2000.1">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hilger-Eversheim</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moser</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schorle</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buettner</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Regulatory roles of AP-2 transcription factors in vertebrate development, apoptosis and cell-cycle control.</article-title>
                <source>Gene.</source>
                <year>2000</year>
                <volume>260</volume>
                <fpage>1</fpage>
                <lpage>12</lpage>
                <pub-id pub-id-type="pmid">11137286</pub-id>
              </element-citation>
            </ref>
            <ref id="bofs.REF.holzschuh.2003.5741">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Holzschuh</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barrallo-Gimeno</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ettl</surname>
                    <given-names>AK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Durr</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Knapik</surname>
                    <given-names>EW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Driever</surname>
                    <given-names>W</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Noradrenergic neurons in the zebrafish hindbrain are induced by retinoic acid and require tfap2a for expression of the neurotransmitter phenotype.</article-title>
                <source>Development.</source>
                <volume>130</volume>
                <fpage>5741</fpage>
                <lpage>54</lpage>
                <pub-id pub-id-type="pmid">14534139</pub-id>
              </element-citation>
            </ref>
            <ref id="bofs.REF.jean.1998.16501">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jean</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gershenwald</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huang</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Luca</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hudson</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tainsky</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bar-Eli</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Loss of AP-2 results in up-regulation of MCAM/MUC18 and an increase in tumor growth and metastasis of human melanoma cells.</article-title>
                <source>J Biol Chem.</source>
                <volume>273</volume>
                <fpage>16501</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">9632718</pub-id>
              </element-citation>
            </ref>
            <ref id="bofs.REF.knight.2003.5755">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Knight</surname>
                    <given-names>RD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nair</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nelson</surname>
                    <given-names>SS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Afshar</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Javidan</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Geisler</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rauch</surname>
                    <given-names>GJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schilling</surname>
                    <given-names>TF</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>lockjaw encodes a zebrafish tfap2a required for early neural crest development.</article-title>
                <source>Development.</source>
                <volume>130</volume>
                <fpage>5755</fpage>
                <lpage>68</lpage>
                <pub-id pub-id-type="pmid">14534133</pub-id>
              </element-citation>
            </ref>
            <ref id="bofs.REF.lee.1982.345">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>WK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Root</surname>
                    <given-names>AW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fenske</surname>
                    <given-names>N</given-names>
                  </name>
                </person-group>
                <year>1982</year>
                <article-title>Bilateral branchial cleft sinuses associated with intrauterine and postnatal growth retardation, premature aging, and unusual facial appearance: a new syndrome with dominant transmission.</article-title>
                <source>Am J Med Genet.</source>
                <volume>11</volume>
                <fpage>345</fpage>
                <lpage>52</lpage>
                <pub-id pub-id-type="pmid">7200726</pub-id>
              </element-citation>
            </ref>
            <ref id="bofs.REF.li.2007.338">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cornell</surname>
                    <given-names>RA</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Redundant activities of Tfap2a and Tfap2c are required for neural crest induction and development of other non-neural ectoderm derivatives in zebrafish embryos.</article-title>
                <source>Dev Biol.</source>
                <volume>304</volume>
                <fpage>338</fpage>
                <lpage>54</lpage>
                <pub-id pub-id-type="pmid">17258188</pub-id>
              </element-citation>
            </ref>
            <ref id="bofs.REF.lin.1995.42">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lin</surname>
                    <given-names>AE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gorlin</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lurie</surname>
                    <given-names>IW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brunner</surname>
                    <given-names>HG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Burgt</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Naumchik</surname>
                    <given-names>IV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rumyantseva</surname>
                    <given-names>NV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stengel-Rutkowski</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosenbaum</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meinecke</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muller</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>1995</year>
                <article-title>Further delineation of the branchio-oculo-facial syndrome.</article-title>
                <source>Am J Med Genet.</source>
                <volume>56</volume>
                <fpage>42</fpage>
                <lpage>59</lpage>
                <pub-id pub-id-type="pmid">7747785</pub-id>
              </element-citation>
            </ref>
            <ref id="bofs.REF.lin.2009.608">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lin</surname>
                    <given-names>AE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yuzuriha</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McLean</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mulliken</surname>
                    <given-names>JB</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Lesser forms of cleft lip associated with the branchio-oculo-facial syndrome.</article-title>
                <source>J Craniofac Surg.</source>
                <volume>20</volume>
                <supplement>Suppl 1</supplement>
                <fpage>608</fpage>
                <lpage>11</lpage>
                <pub-id pub-id-type="pmid">19795528</pub-id>
              </element-citation>
            </ref>
            <ref id="bofs.REF.milunsky.2008.1171">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Milunsky</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maher</surname>
                    <given-names>TA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhao</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roberts</surname>
                    <given-names>AE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stalker</surname>
                    <given-names>HJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zori</surname>
                    <given-names>RT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burch</surname>
                    <given-names>MN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clemens</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mulliken</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lin</surname>
                    <given-names>AE</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>TFAP2A mutations result in branchio-oculo-facial syndrome.</article-title>
                <source>Am J Hum Genet.</source>
                <volume>82</volume>
                <fpage>1171</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">18423521</pub-id>
              </element-citation>
            </ref>
            <ref id="bofs.REF.milunsky.2011.22">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Milunsky</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maher</surname>
                    <given-names>TM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhao</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mulliken</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chitayat</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clemens</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stalker</surname>
                    <given-names>HJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bauer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burch</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ch&#x000e9;nier</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cunningham</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Drack</surname>
                    <given-names>AV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Janssens</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karlea</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klatt</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kini</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klein</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lachmeijer</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Megarbane</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mendelsohn</surname>
                    <given-names>NJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meschino</surname>
                    <given-names>WS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mortier</surname>
                    <given-names>GR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parkash</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ray</surname>
                    <given-names>CR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roberts</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roberts</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reardon</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schnur</surname>
                    <given-names>RE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Splitt</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tezcan</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Whiteford</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wong</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zori</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lin</surname>
                    <given-names>AE</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Genotype-phenotype analysis of the branchio-oculo-facial syndrome.</article-title>
                <source>Am J Med Genet A.</source>
                <volume>155A</volume>
                <fpage>22</fpage>
                <lpage>32</lpage>
                <pub-id pub-id-type="pmid">21204207</pub-id>
              </element-citation>
            </ref>
            <ref id="bofs.REF.misceo.2008.3230">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Misceo</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bj&#x000f8;rgo</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ormerod</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ringen</surname>
                    <given-names>&#x000d8;</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rocchi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Hagen</surname>
                    <given-names>CB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frengen</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>A de novo 6p interstitial deletion and a complex translocation involving chromosomes 2, 6, and 14 in a mildly developmentally delayed patient.</article-title>
                <source>Am J Med Genet A.</source>
                <volume>146A</volume>
                <fpage>3230</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">19012337</pub-id>
              </element-citation>
            </ref>
            <ref id="bofs.REF.nelson.2004.72">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nelson</surname>
                    <given-names>DK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Williams</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Frontonasal process-specific disruption of AP-2alpha results in postnatal midfacial hypoplasia, vascular anomalies, and nasal cavity defects.</article-title>
                <source>Dev Biol.</source>
                <volume>267</volume>
                <fpage>72</fpage>
                <lpage>92</lpage>
                <pub-id pub-id-type="pmid">14975718</pub-id>
              </element-citation>
            </ref>
            <ref id="bofs.REF.nottoli.1998.13714">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nottoli</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hagopian-Donaldson</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Perkins</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Williams</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>AP-2-null cells disrupt morphogenesis of the eye, face, and limbs in chimeric mice.</article-title>
                <source>Proc Natl Acad Sci U S A.</source>
                <volume>95</volume>
                <fpage>13714</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">9811866</pub-id>
              </element-citation>
            </ref>
            <ref id="bofs.REF.orso.2007.87">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Orso</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fassetta</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Penna</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Solero</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Filippo</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sismondi</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Bortoli</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taverna</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>The AP-2alpha transcription factor regulates tumor cell migration and apoptosis.</article-title>
                <source>Adv Exp Med Biol.</source>
                <volume>604</volume>
                <fpage>87</fpage>
                <lpage>95</lpage>
                <pub-id pub-id-type="pmid">17695722</pub-id>
              </element-citation>
            </ref>
            <ref id="bofs.REF.raveh.2000.149">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Raveh</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Papsin</surname>
                    <given-names>BC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Forte</surname>
                    <given-names>V</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Branchio-oculo-facial syndrome.</article-title>
                <source>Int J Pediatr Otorhinolaryngol.</source>
                <volume>53</volume>
                <fpage>149</fpage>
                <lpage>56</lpage>
                <pub-id pub-id-type="pmid">10906521</pub-id>
              </element-citation>
            </ref>
            <ref id="bofs.REF.reiber.2010.994">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Reiber</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sznajer</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Posteguillo</surname>
                    <given-names>EG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000fc;ller</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lyonnet</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baumann</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Just</surname>
                    <given-names>W</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Additional clinical and molecular analyses of TFAP2A in patients with the branchio-oculo-facial syndrome.</article-title>
                <source>Am J Med Genet A.</source>
                <volume>152A</volume>
                <fpage>994</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">20358615</pub-id>
              </element-citation>
            </ref>
            <ref id="bofs.REF.schorle.1996.235">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Schorle</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meier</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buchert</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jaenisch</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mitchell</surname>
                    <given-names>PJ</given-names>
                  </name>
                </person-group>
                <year>1996</year>
                <article-title>Transcription factor AP-2 essential for cranial closure and craniofacial development.</article-title>
                <source>Nature.</source>
                <volume>381</volume>
                <fpage>235</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">8622765</pub-id>
              </element-citation>
            </ref>
            <ref id="bofs.REF.stoetzel.2009.2141">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Stoetzel</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Riehm</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bennouna Greene</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pelletier</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vigneron</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leheup</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marion</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hell&#x000e9;</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Danse</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thibault</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moulinier</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Veillon</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dollfus</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Confirmation of TFAP2A gene involvement in branchio-oculo-facial syndrome (BOFS) and report of temporal bone anomalies.</article-title>
                <source>Am J Med Genet A.</source>
                <volume>149A</volume>
                <fpage>2141</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">19764023</pub-id>
              </element-citation>
            </ref>
            <ref id="bofs.REF.tekin.2009.427">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tekin</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sirmaci</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Y&#x000fc;ksel-Konuk</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fitoz</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sennaro&#x0011f;lu</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>A complex TFAP2A allele is associated with branchio-oculo-facial syndrome and inner ear malformation in a deaf child.</article-title>
                <source>Am J Med Genet A.</source>
                <volume>149A</volume>
                <fpage>427</fpage>
                <lpage>30</lpage>
                <pub-id pub-id-type="pmid">19206157</pub-id>
              </element-citation>
            </ref>
            <ref id="bofs.REF.westmays.1999.46">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>West-Mays</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nottoli</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hagopian-Donaldson</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Libby</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Strissel</surname>
                    <given-names>KJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Williams</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>AP-2alpha transcription factor is required for early morphogenesis of the lens vesicle.</article-title>
                <source>Dev Biol.</source>
                <volume>206</volume>
                <fpage>46</fpage>
                <lpage>62</lpage>
                <pub-id pub-id-type="pmid">9918694</pub-id>
              </element-citation>
            </ref>
            <ref id="bofs.REF.zhang.1996.238">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hagopian-Donaldson</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Serbedzija</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elsemore</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Plehn-Dujowich</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McMahon</surname>
                    <given-names>AP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Flavell</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Williams</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>1996</year>
                <article-title>Neural tube, skeletal and body wall defects in mice lacking transcription factor AP-2.</article-title>
                <source>Nature.</source>
                <volume>381</volume>
                <fpage>238</fpage>
                <lpage>41</lpage>
                <pub-id pub-id-type="pmid">8622766</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="bofs.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="bofs.Author_Notes">
          <title>Author Notes</title>
          <p>As of January, 2011, there is no disease advocacy organization (&#x0201c;support group&#x0201d;) for BOFS. Through Dr. Lin, several parents of children with BOFS have reached out to the families of newly diagnosed individuals.</p>
        </sec>
        <sec id="bofs.Acknowledgments">
          <title>Acknowledgments</title>
          <p>We thank the many families and international colleagues who have supported our research.</p>
        </sec>
        <sec id="bofs.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>31 May 2011 (me) Review posted live</p>
            </list-item>
            <list-item>
              <p>11 January 2011 (al) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
      <sec sec-type="figs-and-tables">
        <title/>
        <fig position="float" id="bofs.F1" orientation="portrait">
          <label>Figure 1. </label>
          <caption>
            <p>Photo of a boy age five years with the BOF syndrome. Details of the molecular findings are reported in <xref ref-type="bibr" rid="bofs.REF.milunsky.2008.1171">Milunsky et al [2008]</xref> (patient 3, age 2 years). He has a right-sided cervical cutaneous defect ("B") which was repaired; bilateral nasolacrimal duct stenosis and hypertelorism ("O"); and bilateral "mini-microform" cleft lip and full nasal tip, with mild upslanting palpebral fissures ("F"). Although he has bilateral bone conduction hearing loss, he prefers traditional aids to bone conduction hearing aids. His smile reveals right-sided lower facial nerve weakness. He attends kindergarten, meeting all of his Individualized Educational Plan goals at the learning center for the deaf. He is very sociable, and both speaks English and signs fluently in American Sign Language. (Photo generously provided by this child's mother.)</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="bofs-Image001" position="anchor" orientation="portrait"/>
        </fig>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
